Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.

Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical ...

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

MINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart compa ...

Our initial experience with the DurAVR ® THV System has been very positive, and we look forward to providing definitive comparative evidence which could transform patient care.” “With the first ...

Operators are excited about a device that avoids transapical access, a limitation of other systems, says Gilbert Tang.

Objective To examine the associations between the number of days per week achieving various daily step thresholds and all-cause mortality and cardiovascular disease (CVD) incidence in older women.

The post-exposure prophylaxis (PEP) vaccines, valued at 100,000 USD, were delivered to the Centres for Disease Control (CDC) ...

Subnautica 2 is currently due to launch in Early Access sometime in 2026. Originally slated to surface this year, confirmation of the delay came back in July, which was then followed by reports from ...

The bells are ringing for Windows 10, and many users who have waited are now choosing to update to Windows 11. If you’re one of them, congratulations on continued security updates and new features, ...